These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9308216)

  • 21. Role of Devices in Insulin Delivery.
    Meneghini LF; McNulty JN
    Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
    [No Abstract]   [Full Text] [Related]  

  • 22. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetes in the elderly, Part II. Finding the balance for drug therapy.
    Cirone N; Schwartz N
    Nursing; 1996 Mar; 26(3):40-5; quiz 46-7. PubMed ID: 8700471
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The perioperative glycemic control in chronic rhinosinusitis coexisting diabetes].
    Zhen H; Gao Q; Peng L; Peng L; Long X; Tao Y; Cui Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jan; 21(2):55-8. PubMed ID: 17438842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rationale for glucose control in diabetes mellitus.
    Nathan DM
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):221-35. PubMed ID: 1612066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 28. [ Change of insulin U40 to insulin U100: comparison of blood insulin and blood sugar in the diabetic patient].
    Scheen AJ; Guiot J; Stassen MP; Jandrain B; Paquot N; Lefèbvre PJ
    Rev Med Liege; 1991 Apr; 46(4):181-7. PubMed ID: 2052811
    [No Abstract]   [Full Text] [Related]  

  • 29. [New flexibility in diabetes therapy].
    Danne T
    MMW Fortschr Med; 2015 Feb; 157(3):65. PubMed ID: 25743681
    [No Abstract]   [Full Text] [Related]  

  • 30. Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis.
    von Lengerke T; Hagenmeyer EG; Gothe H; Schiffhorst G; Happich M; Häussler B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):496-504. PubMed ID: 20496315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-acting basal insulin].
    Meißner T
    MMW Fortschr Med; 2015 Jul; 157(13):82. PubMed ID: 26206056
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new long-acting insulin analog. "Fewer hypoglycemias observed"].
    Gallwitz B
    MMW Fortschr Med; 2004 Jan; 146(3-4):47. PubMed ID: 15035450
    [No Abstract]   [Full Text] [Related]  

  • 33. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
    Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
    Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
    [No Abstract]   [Full Text] [Related]  

  • 34. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 35. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 36. A penny saved.
    Wahowiak L; Duker A
    Diabetes Forecast; 2013 Nov; 66(11):34, 36. PubMed ID: 24298684
    [No Abstract]   [Full Text] [Related]  

  • 37. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications.
    Shichiri M
    Intern Med; 1997 Feb; 36(2):144-7. PubMed ID: 9099605
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of insulin analogs.
    Brixner DI; McAdam-Marx C
    Am J Manag Care; 2008 Nov; 14(11):766-75. PubMed ID: 18999911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patient's opinion of unmet need.
    Hernandez M; Mehr SR
    Am J Manag Care; 2014 May; 20(8 Spec No.):E16. PubMed ID: 25617936
    [No Abstract]   [Full Text] [Related]  

  • 40. [Early-morning hyperglycemia in patients with diabetes mellitus types 1 and 2].
    Jasik M
    Wiad Lek; 1989 Apr; 42(8):529-32. PubMed ID: 2697976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.